Protein Calorie Malnutrition

• Body weight & BMI: Weight in kg ÷ height in m². BMI <18.5 = underweight; <16 = severe undernutrition; <13 = life-threatening. Document baseline at enrollment for trajectory tracking.^[1]
• Weight loss trajectory: Unintentional weight loss >10% over 6 months or >5% over 3 months is clinically significant. This is the single strongest prognostic marker of nutritional decline.^[7]
• Mid-upper arm circumference (MUAC): Essential alternative or supplement to BMI in edematous patients (kwashiorkor edema masks true weight loss). MUAC <23 cm in men or <22 cm in women indicates malnutrition; <19 cm indicates severe wasting.^[1]
• Triceps skinfold thickness: Estimates subcutaneous fat reserves; below 5th percentile for age and sex indicates severe depletion. Limited reliability in edematous patients.

• Serum albumin: Half-life 20 days. <3.5 g/dL = mild malnutrition; <2.8 g/dL = moderate; <2.1 g/dL = severe. Caution: albumin is an acute-phase reactant — falls with any inflammatory state regardless of nutrition. Interpret with CRP.^[8]
• Prealbumin (transthyretin): Half-life 2–3 days; more responsive to acute nutritional changes. <10 mg/dL = severe malnutrition. Useful for short-term monitoring of nutritional response.^[8]
• C-reactive protein (CRP): The acute-phase reactant that contextualizes albumin. Elevated CRP + low albumin = inflammatory suppression ± nutritional depletion. Low CRP + low albumin = primarily nutritional depletion with higher likelihood of refeeding benefit.^[8]
• Total lymphocyte count: <1,500/mm³ suggests protein-energy malnutrition-related immunosuppression; <800/mm³ correlates with severe malnutrition and infection risk.

The Global Leadership Initiative on Malnutrition (GLIM) criteria require at least one phenotypic criterion AND one etiologic criterion:^[7]

• Phenotypic: Weight loss (>5% in 6 mo or >10% beyond 6 mo), low BMI (<20 if <70 yr; <22 if ≥70 yr), or reduced muscle mass (by DXA, BIA, CT, or clinical exam)
• Etiologic: Reduced food intake (<50% of requirements for >1 week or any reduction for >2 weeks), or disease burden/inflammation (acute illness, chronic disease, cachexia)
• Severity staging: Stage 1 (moderate) vs. Stage 2 (severe) — based on BMI thresholds, weight loss percentage, and muscle mass reduction degree

The SGA is the most clinically practical bedside assessment for hospice use — no laboratory values required:^[9]

• SGA-A: Well-nourished — rare at PCM hospice enrollment
• SGA-B: Moderately malnourished or suspected malnutrition — some weight loss, reduced intake, mild subcutaneous tissue loss
• SGA-C: Severely malnourished — obvious muscle wasting, edema, significant weight loss, markedly reduced intake. Most PCM hospice patients are SGA-C at enrollment
• Integrates: weight change, dietary intake change, GI symptoms, functional capacity, and physical exam findings (subcutaneous fat loss, muscle wasting, edema, ascites)

• Mechanism: Chronic caloric deprivation — the body consumes its fat and then its muscle for energy
• Appearance: Severe wasting, visible ribs, temporal wasting, skin over bones, "old man facies"
• Albumin: May be initially preserved (hepatic protein synthesis maintained until late)
• Edema: Absent
• Hospice context: Geriatric failure to thrive, TRAN, chronic dysphagia

• Mechanism: Protein deficiency with relatively preserved caloric intake — the patient eating carbohydrates but no protein
• Appearance: Edematous (pitting edema of extremities, periorbital, ascites), distended abdomen, skin changes (flaky paint dermatosis), hair changes
• Albumin: Severely depressed (<2.5 g/dL typical)
• Danger: Edema masks true weight loss — the patient may appear heavier than they are
• Hospice context: Less common; seen in chronic illness with poor dietary quality

• Mechanism: Combined caloric and protein deficiency — the most common presentation at hospice enrollment
• Appearance: Features of both — wasting with some edema, variable albumin depression, metabolic instability
• Albumin: Moderately to severely depressed
• Clinical significance: Highest refeeding syndrome risk; highest mortality; worst wound healing; most complex medication management
• Hospice context: Advanced cancer cachexia, end-stage organ failure, AIDS wasting

The cachectic state is mechanistically distinct from simple starvation and is driven by the pro-inflammatory cytokines of advanced disease:^[2][5]

• TNF-α (cachectin): Activates the ubiquitin-proteasome pathway in skeletal muscle — the cellular machinery that degrades muscle protein regardless of nutritional intake. Suppresses appetite centrally. Increases resting energy expenditure.
• IL-6: Drives hepatic acute-phase response, diverting albumin synthesis toward CRP and other acute-phase proteins. Promotes muscle proteolysis. Induces insulin resistance.
• IL-1β: Central appetite suppressant. Induces fever and hypermetabolism. Contributes to the negative nitrogen balance that makes muscle rebuilding impossible.
• Proteolysis-inducing factor (PIF): Tumor-derived factor directly activating skeletal muscle degradation. Present in urine of cancer cachexia patients. Not present in starvation.

The clinical implication that shapes every nutritional decision in cachexia:^[12]

• The metabolic trap: Increased caloric intake in cachexia does not increase lean body mass — it may increase fat mass slightly while muscle wasting continues unabated. The cytokine cascade is upstream of the nutritional input.
• Artificial nutrition in cachexia: Cochrane reviews demonstrate no survival benefit and no quality-of-life benefit from artificial nutrition in advanced cancer cachexia. Parenteral nutrition in cachectic cancer patients is associated with increased complications without improved outcomes.^[13]
• The family message: "The problem is not that she is not eating enough. The problem is that the disease has changed how her body uses what she eats. More food cannot fix what the disease has broken." This is the hardest sentence in PCM hospice.
• What feeding CAN provide in cachexia: Oral pleasure, social connection at mealtimes, the human dignity of being offered food. Comfort feeding — not nutritional repletion — is the appropriate framework.

• Simple starvation with intact metabolic machinery: The patient with dysphagia or mechanical obstruction who has no cachexia-driving disease and whose malnutrition is purely from insufficient intake — enteral or parenteral nutrition can provide genuine benefit when refeeding protocol is followed^[17]
• Proximal bowel obstruction with longer prognosis: The patient with malignant obstruction who cannot eat but whose overall trajectory suggests months of survival — parenteral nutrition may provide symptomatic and functional benefit
• Patient or family distress from hunger or thirst: When the patient reports distress from hunger or thirst not relievable by comfort oral intake or mouth care, subcutaneous hydration or low-rate enteral feeds may provide comfort benefit
• TRAN patients who request it: The patient with treatment-resistant anorexia nervosa who, having made autonomous decisions about their care, requests nutritional support — provide it with the refeeding protocol and respect for their autonomy in both directions

• Advanced cachexia from cancer, HF, or other primary disease: Cochrane evidence demonstrates no survival benefit and no quality-of-life improvement from ANH in advanced cancer cachexia. The cytokine cascade overrides caloric input.^[13]
• Advanced dementia: Finucane 1999 (JAMA) — tube feeding in advanced dementia does not prevent aspiration pneumonia, does not prevent pressure ulcers, does not improve functional status, does not improve comfort, and does not prolong life. The evidence is unambiguous.^[17]
• Active dying phase: ANH in the final days increases secretions, worsens dyspnea, and prolongs dying without improving comfort
• Without refeeding protocol: ANH in any severely malnourished patient without the refeeding syndrome prevention protocol may cause death faster than the malnutrition itself

The evidence for thiamine deficiency in severe malnutrition and the risk of Wernicke's encephalopathy with carbohydrate reintroduction is unambiguous. Thiamine deficiency produces Wernicke's encephalopathy; carbohydrate administration in thiamine-depleted patients precipitates Wernicke's by consuming remaining thiamine reserves in glucose metabolism. The Wernicke's that develops after a glucose infusion in a malnourished patient is a preventable iatrogenic neurological emergency.^[14]

• For very-high-risk patients (anorexia nervosa, chronic alcohol use + malnutrition, prolonged starvation >14 days), parenteral thiamine is preferred due to unreliable GI absorption
• The cost is pennies. The failure to provide it is a clinical error. Document thiamine as a required pre-feeding medication at enrollment
• The family who has been giving protein shakes without thiamine supplementation to a severely malnourished patient has been unknowingly creating the conditions for Wernicke's

The NICE 2006 guidelines represent the most widely accepted clinical standard for refeeding syndrome prevention. Adapted for hospice comfort context:^[3][10]

• High-risk criteria (≥1): BMI <16; unintentional weight loss >15% in 3–6 months; little or no intake for >10 days; low phosphate, potassium, or magnesium before feeding
• Very-high-risk criteria (≥1): BMI <14; negligible intake for >15 days; any pre-feeding electrolyte below reference range
• In the hospice setting, the refeeding protocol applies to comfort oral feeding as well — the patient who transitions from minimal intake to enthusiastic eating of comfort foods can develop refeeding syndrome if intake increases rapidly without monitoring
• The protocol is not an obstacle to feeding — it is the safe pathway to feeding. Present it to families as: "We want to feed her safely. This is how we do that."

Palecek et al. (2010) proposed the "comfort feeding only" approach as a formalized alternative to tube feeding in advanced illness — providing a documented, evidence-based framework for what had previously been an informal practice:^[16]

• Prioritizes oral pleasure, social connection at mealtimes, and the dignity of being offered food — over caloric delivery
• Requires explicit documentation and family training to prevent the drift back to intake monitoring
• Associated with equivalent or better patient comfort compared to tube feeding in advanced illness populations
• The word "only" in "comfort feeding only" can be reframed for families: "This is comfort feeding first — feeding that centers your person's experience rather than a number"

Bruera and colleagues demonstrated that subcutaneous hydration provides comfort equivalent to IV hydration with fewer complications and greater home-care compatibility:^[20]

• No IV access required — avoidance of venipuncture, central line complications, and infection risk
• Can be administered by trained family caregivers in the home setting
• Provides the visible "giving of fluids" that addresses family distress about dehydration while maintaining comfort-appropriate volumes
• Particularly valuable in the PCM patient with poor venous access from edema, wasting, or repeated prior cannulation attempts
• Caution: avoid in patients with severe generalized edema or anasarca where additional fluid worsens discomfort

Chochinov's dignity therapy addresses the existential and identity distress that is amplified in PCM patients by the visible physical transformation of severe wasting:^[26]

• Particularly valuable for PCM patients whose changed body (hollowed face, visible bones, dramatic weight loss) has altered how they are seen by others and how they see themselves
• For TRAN patients: provides a structured way to process the complex relationship with the body that has defined their entire adult life
• RCT evidence demonstrates reduced suffering, increased sense of meaning, and improved family experience
• The generativity document — a transcribed and edited narrative of the patient's life story, values, and legacy messages — becomes a lasting gift to the family

Mirtazapine provides the most favorable risk-benefit profile among appetite stimulants in PCM hospice, addressing multiple symptoms simultaneously:^[25]

• Appetite stimulation: H1 receptor antagonism and 5-HT2C antagonism produce weight gain and appetite increase — the "side effect" that becomes the therapeutic effect in PCM
• Sedation at lower doses: 7.5 mg produces more sedation than 15 mg (paradoxically) — addresses insomnia common in malnourished patients
• Antidepressant effect: Noradrenergic and serotonergic mechanism addresses depression that frequently co-occurs with severe malnutrition
• Anti-nausea effect: 5-HT3 antagonism provides antiemetic benefit
• Preferred over megestrol (thromboembolic risk, adrenal suppression) in the PCM hospice population

Oral electrolyte replacement is the foundation of refeeding syndrome prevention in the home hospice setting where IV access is often impractical:^[3]

• Potassium phosphate: Addresses both hypophosphatemia and hypokalemia simultaneously — the dual deficiency common in severe malnutrition. Liquid formulations available for patients with dysphagia
• Magnesium glycinate: Better tolerated than magnesium oxide (less diarrhea). Critical because hypokalemia is refractory to correction without concurrent magnesium repletion
• Monitoring: Serum levels q48h during initial correction phase; weekly once stable. Adjust doses to maintain phosphate >3.0, potassium >3.5, magnesium >1.8
• Oral replacement may be insufficient in severe depletion — have threshold for subcutaneous or IV correction if oral route fails to correct within 48–72 hours

The severely malnourished body has specific needs for therapeutic touch that differ from the general hospice population:

• Skin fragility in severe malnutrition requires lighter pressure than standard massage — effleurage (gliding) rather than petrissage (kneading)
• Provides human contact with a body the patient may feel is "ugly" or "skeletal" — the touch communicates that the body is still worthy of gentle care
• Small case series suggest reduced anxiety, improved sleep, and decreased pain perception in malnourished palliative patients
• For TRAN patients: therapeutic touch can be complex given the body-relationship history. Obtain explicit consent and respect boundaries. Some TRAN patients find gentle touch profoundly healing; others experience it as intrusive
• Avoid over bony prominences with active or impending pressure injury

In many cultures, specific foods carry spiritual, healing, or relational significance that transcends their nutritional content:

• Cultural foods as medicine: The chicken soup, the congee, the bone broth, the special tea — families may bring foods with deep cultural significance. Integrate these into the comfort feeding framework rather than restricting them
• Feeding rituals: The specific person who feeds (eldest daughter, spouse, religious figure), the prayers over food, the communal mealtime — preserve and honor these rituals as comfort interventions
• Safety coordination: Ensure culturally significant foods are consistent with the refeeding protocol (no sudden high-calorie boluses) and texture modifications for swallowing safety. This is a "yes, and" conversation — not a "no"
• Expert opinion and clinical experience consistently support integrating cultural feeding practices as a core comfort strategy — the evidence base is anthropological and relational rather than clinical trial-based

Megestrol is the most widely studied appetite stimulant for cancer-related anorexia-cachexia, with demonstrated appetite improvement and modest weight gain:^[27]

• Meta-analyses confirm appetite improvement in approximately 60–70% of patients and modest weight gain — though weight gain is predominantly fat, not lean mass
• Significant risks in the PCM population: Thromboembolic events (DVT, PE) — particularly concerning in bedbound malnourished patients already at elevated thrombotic risk
• Adrenal suppression with prolonged use — do not discontinue abruptly; taper if stopping
• In the comfort framework: megestrol may improve appetite and the subjective experience of eating, even if it does not reverse cachexia. The comfort benefit may justify the risk for selected patients with a prognosis of months
• Not recommended in patients with known thromboembolic history or advanced cardiac cachexia

The family member who has spent a lifetime expressing love through cooking — the mother who made chicken soup, the daughter who brings tamales, the husband who always knew what his wife liked — is now told that the person they love cannot eat what they have prepared, or that feeding must be slow, or that the tube was removed. This is not a small loss. It is a fundamental rupture in the caregiving relationship.

• Ask explicitly: "What has it been like not to be able to feed her the way you want to?" — This question opens the conversation about a specific grief that is rarely named^[47]
• Reframe the caregiving: Help the family find new ways to express love through food-adjacent acts — lip moistening with favorite flavors, ice chips made from favorite beverages, the presence at mealtime even when nothing is eaten
• Validate the grief of the unfulfilled feeding impulse: "It makes sense that this is hard. Feeding the people we love is one of the most human things we do."

Cultural, religious, and ethnic communities hold profoundly different views on the moral and spiritual significance of providing nutrition to a dying person. These views are not obstacles to overcome — they are values to be understood and integrated into the care plan.

• Many Catholic, Jewish, and Muslim traditions view providing food and water as basic care, not medical treatment — the distinction between ANH as medical intervention versus basic sustenance is understood differently across traditions^[48]
• Latino, Asian, and African American families may experience cessation of nutrition as abandonment — the cultural narrative of "letting them starve" carries profound moral weight
• Clinical approach: Ask before you tell. "In your family and your culture, what does it mean to feed someone who is ill?" Listen fully. Then share the clinical evidence as information — not as prescription. Document both the cultural context and the clinical discussion.

Chochinov's dignity therapy — a structured life narrative intervention — is particularly relevant for PCM patients whose visible wasting may undermine their sense of self-worth and identity. The protocol creates a generativity document that becomes a permanent legacy.^[49]

• Core question: "What do you most want your family to remember about you?" — both assessment and intervention
• For TRAN patients: The legacy document may be the first opportunity to define themselves as something other than their eating disorder
• For all PCM patients: The document provides the family with a tangible connection to their person's identity beyond the wasted body

• "What is your understanding of where things stand with the nutrition situation?" — assesses illness understanding before prognostic disclosure
• "If we could get you the most comfortable possible, what would that look like?" — surfaces values without triggering defensiveness about food
• "What are you most worried about?" — often reveals fear of suffering, of burdening family, or of dying hungry
• "Tell me about a meal that mattered to you." — connects the current loss to the person's whole life history with food
• Do not have this conversation standing up. Sit down. Make eye contact. Leave silence. The patient will fill it.